Reducing sympathetic neurohormone expression is a key therapeutic option in attenuating cardiac remodelling. Present study tested the feasibility of attenuating cardiac remodelling through reducing sympathetic neurohormone level by partial cardiac sympathetic denervation in a rat model of chronic volume overload. Male Sprague-Dawley rats were randomized into sham group (S, n = 7), aortocaval fistula group (AV, n = 7), and aortocaval fistula with bilateral sympathetic stellate ganglionectomy group (AD, n = 8). After 12 weeks, myocardial protein expression of sympathetic neurohormones, including tyrosine hydroxylase, neuropeptide Y, growth associated protein 43, and protein gene product 9.5, were significantly up-regulated in AV group compared to S group, and down-regulated in AD group. Cardiac remodelling was aggravated in AV group compared to S group and attenuated in AD group. The myocardial deposition of extracellular matrix, including collagen I and III, was enhanced in AV group, which was reduced in AD group. Myocardial angiotensin II and aldosterone expressions were significantly up-regulated in AV group and downregulated in AD group. Our results show that bilateral sympathetic stellate ganglionectomy could attenuate cardiac remodelling and fibrosis by down-regulating sympathetic neurohormones expression in this rat model of chronic volume overload.
attenuation and, over time, progressively pathological augmentation of sympathetic out-flow, this sympathetic/parasympathetic imbalance occurs steadily irrespective of the etiology of heart failure. [5] [6] [7] Modalities, including strategies modulating the autonomic nervous system, are intensively searched to correct this dangerous "autonomic imbalance" in the setting of heart failure. 5 Previous studies demonstrated that drug therapy aimed to block the SNS and renin-angiotensinaldosterone systems (RAAS) consistently reduced morbidity and mortality in chronic heart failure patients with reduced LV ejection fraction. 8 Besides β-blocker, researchers also explored other strategies to reduce the secondary damage induced by excessive release of sympathetic hormones on the failing heart. 9, 10 One promising option is the blockade or removal of sympathetic ganglion. It was shown that surgical removal of sympathetic ganglion via ganglionectomy could denervate the heart and reduce the activity of cardiac sympathetic neurohormones including norepinephrine, tyrosine hydroxylase (TH), and neuropeptide Y (NPY) etc. 11 Neurohormone TH, NPY, growth associated protein 43 (GAP43), and protein gene product 9.5 (PGP9.5) were the biomarkers of SNS, the neurohormone level could reflect SNS activity. Previous studies showed that, TH served as a sympathetic nerve marker. NPY was the neurotransmitter substance in neurons and postulated to be responsible for sympathovagal crosstalk. GAP43 played a crucial role in neural development, axonal regeneration, and structural plasticity. Panneuronal marker PGP9.5 was the marker of neuron fiber, which indicated the function of the autonomic nervous system. [11] [12] [13] [14] Schwartz and colleagues demonstrated the beneficial effect of cardiac sympathetic denervation on suppressing ventricular tachycardia (VT) and fibrillation (VF) in patient refractory to VT ablation. [15] [16] [17] Similarly, Shivkumar and associates also showed that bilateral cardiac sympathetic denervation was an effective therapeutic strategy to treat patients with VT, VF, and electrical storm. [18] [19] [20] Above studies thus indicated that cardiac denervation via sympathectomy is a clinically feasible strategy to partial denervate the heart and treat patients with malignant ventricular arrhythmias. Results from these studies also hint the possibility to alleviate the secondary damage of excessive release of sympathetic hormones on the failing heart by means of cardiac sympathetic denervation. In fact, beneficial effects had been observed in patients with chronic heart failure treated with left cardiac sympathetic denervation. 21 A prospective clinical study is now underway to assess the effect of left cardiac sympathetic denervation in patients with chronic heart failure. 22 Till now, the effect and mechanism of ganglionectomy on experimental heart failure models are not fully understood. Previous clinical studies demonstrated that bilateral sympathectomy was a preferred option for the treatment of refractory ventricular tachycardia versus left sympathectomy, as the efficacy of left sympathectomy alone on preventing or reducing the incidence of malignant ventricular arrthymias was sometimes suboptimal. 20, 23, 24 Symmetric distribution of sympathetic nerve in left and right heart belonged to the usual biological feature, bilateral sympathetic stellate ganglionectomy (SGX) might thus be helpful to re-establish the sympathetic balance at lower level, we thus chosen the bilateral SGX strategy as a tool to partially reduce the overactivated sympathetic activity in the failing heart. In the current study, we tested the hypothesis that bilateral SGX surgery might be an effective strategy for the partial denervating of the heart via lowering the expression of cardiac sympathetic neurohormones, and subsequently attenuating the cardiac remodelling in a rat model of sustained volume overload. housed under standard conditions with free access to food and drinking water. Rats received a normal salt diet (0.3% NaCl) throughout the study.
| MATERIALS AND METHODS

| Animal preparation and study protocol
The first surgery was performed to establish the aortocaval fistula (AV) model in anaesthetized (40 mg/kg sodium pentobarbital intraperitoneally) rats. Ventral abdominal laparotomy was performed in anaesthetized rats, the intestines were displaced laterally and wrapped with normal saline-soaked sterilized gauze to retain moisture. The aorta and vena cava between the levels of renal arteries and iliac bifurcation were then exposed by blunt dissection of the overlaying adventitia. Both vessels were temporarily occluded proximal and distal to the intended puncture site, and a 18-gauge needle held on a plastic syringe was inserted into the exposed abdominal aorta and advanced through the medial wall into the vena cava to create the shunt. The needle was gently inserted and withdrawn across the medial wall several times through the same puncture hole, to ensure the establishment of the fistula, before the needle was finally withdrawn from the aorta. The ventral aortic puncture site was immediately sealed with a drop of cyanoacrylate (Medical Adhesive Glue; Baiyun Medical Adhesive Co., Guangzhou, China) after withdrawal of the needle. Creation of a successful fistula was confirmed by visualizing the pulsatile flow of oxygenated blood into the vena cava from the abdominal aorta. The intestines were repositioned, and the abdominal musculature and skin incisions were closed by standard techniques with absorbable suture and autoclips. 25 
| Stellate ganglionectomy surgery
The partial denervation of the cardiac sympathetic nerves was accomplished by bilateral SGX. It was technically difficult to perform the surgical removal of bilateral stellate ganglion at one operation session. To improve the survival of rats assigned for SGX, we choose to achieve the bilateral SGX at two separate operative sessions at 1-week interval (at 7th and 14th days post AV).
Seven days post AV operation, rats were re-anaesthetized, intubated endotracheally using a 16 G intravenous catheter connected to a ALCOTT rodent ventilator (model ALC-V8S, China). The ventilator was set at 65 cycles/min and 2.5 mL stroke volume. Following a right sided skin incision, thoracotomy was performed by cutting the second rib on the right side. The incision was retracted, and the right lung was gently pulled caudally using sterile saline-soaked gauze. A surgical microscope (model JSZ6, RWD, China) was used to visualize the right stellate ganglion between the first and second ribs beneath the parietal pleura ( Figure 1A -a). All nerve branches running into the ganglion were isolated and cut, the ganglion was excised, and the gauze was removed. The removed stellate ganglion was stained with Nissl staining ( Figure 1A-b ). A left SGX was performed using the same procedure on the left side 1 week later. The thorax was closed after each operation session. A negative intrathoracic pressure was re-established by inserting a 23-gauge needle into the thoracic cavity and suctioning air with a 3-ml syringe. All rats underwent SGX exhibited ptosis the day after surgery, an initial indicator of a successful ganglionectomy. 26 
| Echocardiography examination
| Blood and tissue collection and biochemistry examination
After echocardiographic examination and blood sampling from vena cava, the rats were killed under additional deep anaesthesia. After washing out the blood of the rat hearts, heart from three randomly selected rats from each group was longitudinally divided into two portions, one portion for gross morphology, another portion for histological examinations. The remaining four hearts of S and AV group, and five hearts of AD group were used for the measurement of total heart weight, then the hearts were divided into atria, right ventricular (RV) and left ventricular (LV) including the septum parts and each part was weighed, then frozen at −80°C for future molecular biological examinations. One portion longitudinal three hearts which randomly selected from each groups were embedded in paraffin. Tissue sections were stained with haematoxylin-eosin (HE), Sirius red staining and immunohistochemistry methods, respectively, and images were then captured with a Leica microscope (DMi8; Wetzlar, Germany). Another portion longitudinal three hearts were fixed in neutral formaldehyde for 1 week, the hearts were then blotted dry to present the size of the cavity and thickness of the RV and LV walls. Angiotensin II (Ang II) concentrations in the plasma was measured with the ELISA kit (Ray-Bio, EIA-ANG II, Norcross, GA, USA) following manufacturer's instructions. The absorbance was recorded at 450 nm. Table S1 . Relative gene expression was calculated using the 2 −ΔΔCT method. Primers sequences are provided in the Supporting Information. 
| Pathology examination
| Western blotting
| Statistical analysis
All data were presented as mean ± SD and assessed by one-way ANOVA among the groups. The data were analyzed by Tukey′s post hoc test or Games-Howell test to test the difference between the means of various groups and P < 0.05 was considered as statistically significant (SPSS Statistics 21.0 and GraphPad Prism 5.0).
| RESULTS
| Survival
All seven rats assigned to sham operation survived to the study end. 
| Impact of SGX on neurohormones expression in chronic volume overload rats
As shown in Figure 1B Figure 1C ). Figure 2A , protein expression of GAP43 and PGP9.5 tended to be higher in AV group compared to S group in LV (P = 0.067, P = 0.088). Immunohistochemistry results showed that protein expression of TH, GAP43 and PGP9.5, and NPY was significantly up-regulated in AV group as compared to S group in LV.
As shown in
Above changes were not significantly affected by SGX ( Figure 2B ).
| Impact of SGX on cardiac remodelling and function
Echocardiography examination showed that LVIDd and LVIDs were significantly increased in AV group (vs S group) (P < 0.01), which were significantly reduced in AD group (P < 0.01 vs AV). EF and FS were significantly reduced in AV group (P < 0.01 vs S), which tended to be higher in AD group compared to AV group ( Figure 3A) . As expected, heart enlargement, and RV and LV cavity dilation as well as hypertrophied wall thickness were observed in the vertically cut hearts of the AV group and these changes were less apparent in AD group ( Figure 3B ). Bodyweight was similar among groups, heart, and RV and LV weights were significantly increased in AV group than in S group, which were significantly reduced in AD group (Table 1 ).
| Impact of SGX on cellular remodelling and myocardial hypertrophy markers
HE results demonstrated that cardiomyocyte cross-sectional area in both RV and LV were significantly larger in AV group than in S group (P < 0.05). The cardiomyocyte cross-sectional area of RV was significantly smaller in AD group than those in AV group (P < 0.05) ( Figure 4A ). Meanwhile, myocardial mRNA expressions of ANP and F I G U R E 1 A, The stellate ganglion was exposed under the surgical microscope. All nerve branches running into the ganglion and the ganglion were isolated and excised (a, ×10). The ganglion was processed for paraffin embedding and sliced into 4 μm tissue sections, stained blue with Nissl staining (Arrow) (b, ×200). B, Protein expression of sympathetic neurohormones in RV. Protein expression of TH, NPY, GAP43 and PGP9.5 in RV were up-regulated in AV group (vs S group) and protein expression of GAP43 and PGP9.5 was downregulated in AD group (vs AV group) (*P < 0.05,**P < 0.01). (S, AV and AD, n = 4). C, Immunohistochemistry staining of sympathetic neurohormones in RV. The protein expression of TH, NPY, GAP43 (**P < 0.01) and PGP9.5 (*P < 0.05) was increased in AV group (vs S group) and protein expression of GAP43 (**P < 0.01) was reduced in AD group compared to AV group in RV (×400). (S, AV and AD, n = 3) F I G U R E 2 A, Protein expression of sympathetic neurohormones in LV. Protein expression of GAP43 and PGP9.5 tended to be higher in AV group compared to S group in LV (P = 0.067, P = 0.088). (S, AV and AD, n = 4). B, Immunohistochemistry staining of sympathetic neurohormones in LV. The protein expression of NPY (**P < 0.01), TH, GAP43 and PGP9.5 (*P < 0.05) were significantly increased in AV group compared to S group in LV (×400). (S, AV and AD, n = 3) BNP, known as myocardial hypertrophy markers, 32 were significantly up-regulated in RV of AV group (P < 0.01 vs S), mRNA expression of ANP in RV was significantly down-regulated in AD group compared to AV group, while ANP and BNP expressions were similar among groups in LV ( Figure 4B ). We also observed the perivascular coronary fibrosis and found that the perivascular fibrosis ratio was similar among groups ( Figure S1 ).
| Impact of SGX on myocardial extracellular matrix and fibrosis
Results from Sirius red stained heart sample showed that the percentage of collagen deposited was significantly increased in RV and LV in rats from AV group (P < 0.01 vs S group), which was significantly reduced in AD group in RV (P < 0.05 vs AV group) ( Figure 5A Figure 6B ).
| DISCUSSION
Sustained increased sympathetic neurohormones can lead to secondary heart damage after the initial insult. 33 In this study, chronic volume overload was applied to rats for 12 weeks and sympathetic activation and cardiac remodelling were demonstrated in this model.
Our results revealed that "partial cardiac denervation" achieved by bilateral SGX could attenuate myocardial remodelling and fibrosis, and these effects were associated with reduced myocardial sympathetic neurohormones expression, especially in the right ventricle. To our best knowledge, this is the first experimental study reporting on major pathological feature in this model. In this AV model of rats, RV and LV faced various loading burden. Previous experimental studies demonstrated that, besides to deal with the same increased circulating volume in RV and LV, RV also faced an increased pressure load from the increased pulmonary systolic pressure in this model. 36, 37 This might partly explain the stronger sympathetic activation observed in the RV than in the LV in this model.
| Impact of SGX on cardiac remodelling and neurohormones
Heart receives multiple sympathetic dominance, which includes the superior cervical nerve, the middle cervical, and the stellate nerve. The selective removal of the stellate ganglion could be viewed as "partial cardiac denervation" and capable of decreasing sympathetic activity of the heart partly. Cardiac sympathectomy can be achieved by direct surgical approaches 38 or by video-assisted thoracoscopic surgery. 39 Multiple procedures are reported to achieve the cardiac sympathectomy clinically. Schneider et al dissected the left stellate ganglion in two halves, separated the first thoracic part from the inferior cervical part.
The cephalic portion of the stellate ganglion was preserved to prevent Horner syndrome. Then the thoracic ganglia T2-T4/T5 and their associated rami communicantes were removed. 38 Kopecky et al reported successful experience of bilateral video-assisted thoracoscopic surgery with T1-T4 sympathectomy for treatment of refractory ventricular tachycardia. 24 Our initial goal is to achieve a "partial cardiac denervation" in the chronic volume overload model of rats to preserve some functional responses of the sympathetic nerve despite the bilateral SGX. Previously, Gan et al performed the cardiac sympathetic denervation through bilateral SGX plus transection of T1-T4 sympathetic rami in rats with experimental myocardial infarction. 40 As the SGX surgery denervated heart partly, it did not induce denervation supersensitivity. 41 Previous studies have confirmed the pathophysiology of heart failure resulted in neurohormonal activation and autonomic imbalance with increase in sympathetic activity and withdrawal of vagal activity. 42 Peter J. Schwartz showed that SGX increased cardiac vagal efferent activity. 43, 44 Based on the close correlation between sympathetic neurohormonal activity and cardiac remodelling in this model, we assumed that secondary cardiac damage induced by excessive sympathetic activation could be partly blocked by bilateral SGX despite the persistent existence of volume overload in this model. Accordingly, our study results demonstrated that cardiac remodelling attenuation was achieved by this "partial cardiac denervation" proposal. Compared to AV group, the sympathetic hormones marker including TH, GAP43, PGP9.5, and NPY were significantly down-regulated in AD group, especially in the RV, indicating reduced cardiac sympathetic activity postbilateral SGX (Figures 1 and 2) . Besides attenuated myocardial remodelling, the myocardial fibrosis was also reduced by bilateral SGX, suggesting the regulation of cardiac sympathetic neurohormone activity could also beneficially affect the cardiac matrix deposition. Previous study showed that vagal nerve activity modulation also affected the cardiac remodelling, 45 future studies are warranted to test the impact of SGX on vagal nerve activity and remodelling in this study.
It is to note that the influence of bilateral SGX was stronger in the RV than in the LV in this model. Sympathetic neurohormones level reduction post-bilateral SGX was more significant in RV than in LV in this model. 4.3 | Impact of SGX on renin-angiotensinaldosterone system and sympathetic nervous system SNS and RAAS are the two major neurohormonal systems, which play crucial role in both physiological and pathological conditions. Experimental and clinical data 1 showed that the progression of heart failure was the result of activation of many bioactive factors, including mediators of SNS and RAAS. Ang II and aldosterone levels, which characterize the activation of the RAAS. In the case of heart failure, the early compensatory mechanism was the sympathetic nervous system activation, while RAAS activated relatively late. Ang II could stimulate the production of aldosterone by enhancing sympathetic released adrenaline and adrenal cortical globular bands, aldosterone can further activate the SNS. 46 Mounting evidence indicate that RAAS is actively involved in the pathogenesis of heart failure. 47, 48 The interaction between SNS and RAAS in the case of heart failure is schematically presented in the Figure S2 .
Our study shows that bilateral SGX also reduced the activity of RAAS in cardiac tissue, as shown by reduced expression of Ang II and aldosterone in the AD group as compared to AV group ( Figure 6 ).
These results suggested that lowering SNS activity by bilateral SGX could also effectively affect the RAAS axis and reduced RAAS activity. 
| Study limitations
There are several study limitations of our experiments.
1. The animal numbers were small and the time course of partial cardiac sympathetic denervation was not observed in this model, cautions are therefore needed on interpretation of the current ZHANG ET AL. study results. Studies are needed to explore the impact of SGX in animal models with long-standing (more time points) and overt cardiac remodelling to observe if SGX strategy might be also beneficial or not to reverse the preexisting cardiac remodelling because of chronic volume or pressure overload.
2. The changes of sympathetic neurohormones post-bilateral SGX was multiple and also affected vagal nerve activity changes. Present study focused on the myocardial sympathetic mediator changes in the setting of chronic volume overload and SGX, future studies are warranted to explore the impact of SGX on vagal nervous system and the autonomic imbalance between sympathetic activity and vagal activity in the setting of chronic volume overload and SGX.
3. In this study, we observed considerable benefits of the "partial cardiac denervation" through bilateral SGX in this model, however, the potential clinical advantage of the bilateral SGX over the more and more extensive denervation remains unknown now, future studies are warranted to compare the effects of bilateral SGX vs more extensive cardiac denervation in this model. 4 . It is to note that presentation of data of the Northern blots for the RNA expression of ANP and BNP in RV and LV tissues might be helpful to reflect the disease process and the effects of bilateral SGX in this model, because of technical limitations of our laboratory, these data were not determined and further studies are needed to explore related issues. We have also no data on the ratio of the newly synthetized collagen type I to degraded/denaturated collagen I, which is another study limitation of this experimental study.
| CONCLUSION
In conclusion, our study indicates that "partial cardiac denervation" by bilateral SGX could attenuate cardiac remodelling and fibrosis by reducing myocardial sympathetic neurohormones expression in this rat model of chronic volume overload, these beneficial effects are at least partly mediated by reduced myocardial sympathetic and RAAS activities. Our study provides initial experimental evidence and potential mechanism of bilateral SGX for the treatment of heart failure induced by chronic volume overload. 
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